SCHEDULE 13G/A: Maverick Capital Affirms 8% Stake in Curis, Inc. Through Latest SEC Filing
Beneficial Ownership Report (Schedule 13G)
Maverick Capital, Ltd., along with its affiliates Maverick Capital Management, LLC and Lee S. Ainslie III, has filed an amended Schedule 13G, confirming their beneficial ownership of 8% of Curis, Inc.'s common stock.
Summary
- Maverick Capital, Ltd., Maverick Capital Management, LLC, and Lee S. Ainslie III collectively beneficially own 681,381 shares of Curis, Inc. Common Stock.
- This ownership represents 8% of the outstanding shares of Curis, Inc.
- The calculation of the percentage is based on 8,466,957 outstanding shares of Common Stock as reported in Curis, Inc.'s Quarterly Report on Form 10-Q filed on November 14, 2024.
- The aggregate amount of beneficially owned shares includes 49,554 shares from the assumed exercise of warrants held by the Reporting Persons.
- Maverick Capital, Ltd. acts as the investment advisor for several funds, including Maverick Fund USA, Ltd., Maverick Fund II, Ltd., Maverick Long Enhanced Fund, Ltd., Maverick HP, L.P., and Maverick Long Fund, Ltd., which collectively hold the shares and warrants.
- Maverick Capital Management is the General Partner of Maverick Capital, Ltd., and Lee S. Ainslie III is the manager of Maverick Capital Management and the Managing Partner of Maverick Capital, Ltd.
Sentiment
Score: 6
Explanation: The document is a factual report of beneficial ownership. The confirmation of a significant 8% stake by a reputable institutional investor like Maverick Capital is generally viewed as a positive signal of confidence in the company, although the filing itself does not contain forward-looking statements or operational performance details.
Positives
- The filing indicates a significant and continued institutional investment in Curis, Inc. by Maverick Capital, suggesting confidence from a sophisticated investor.
- Maverick Capital, as a registered investment adviser, exercises investment discretion over these holdings, implying active management of the position.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership by an institutional investor in a publicly traded company within the biotechnology sector. It reflects an investment position rather than operational or strategic updates from the company itself.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional holder can influence investor perception and potentially provide a degree of stability or confidence in the stock.
Key Dates
| Date | Description |
|---|---|
| 2018-03-15 | Date of Power of Attorney for signature |
| 2024-11-14 | Date Curis, Inc. filed its Quarterly Report on Form 10-Q, providing the basis for outstanding shares calculation |
| 2024-12-31 | Date of Event Which Requires Filing of this Statement (reporting period end) |
| 2025-02-14 | Date of filing of this Schedule 13G Amendment No. 3 |
Keywords
Curis Inc, Maverick Capital, Schedule 13G, beneficial ownership, common stock, institutional investor, CU, biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.